Fundraising Fox
Solid Biosciences
NASDAQ: SLDBCharlestown, US · Delaware corporation · 4 known investors
Find your way into Solid Biosciences
Sign up to see every warm intro you have to Solid Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Solid Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Solid Biosciences is a precision genetic medicine company developing a pipeline of gene therapy candidates for rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich's ataxia, CPVT, and TNNT2-mediated dilated cardiomyopathy. It also develops genetic regulator libraries and delivery platform technologies intended to improve gene therapy delivery.
Founders & leadership
Board
Investors · 4
How we know: Bain Capital Life Sciences's portfolio page · board seat on SEC Form D · funding news · Not right? Tell us
How we know: Foresite Capital's portfolio page · Not right? Tell us
How we know: RA Capital's portfolio page · the S-1 prospectus · funding news · Not right? Tell us
How we know: baincapital.com · Not right? Tell us
Funding
SEC filings, press & company announcements$109.2M disclosed across 3 of 5 rounds · 2017–2026
▶$9.2MraisedDec 2022 · 13 investors · PharmaceuticalsRule 506(b)
- Lynne SullivanDirector
- Adam KoppelDirector
- Stephen DiPalmaExecutive Officer
- Martin FreedDirector
- Alexander (Bo) CumboExecutive Officer, Director
- Paul HerizchExecutive Officer
- Clare KahnDirector
- Georgia KerestyDirector
- Adam StoneDirector
- Rajeev ShahDirector
- Robert HuffinesDirector
- Carl MorrisExecutive Officer
- Jessie HanrahanExecutive Officer
- Sukumar NagendranDirector
- Ilan GanotDirector
- David Tyronne HowtonExecutive Officer
- Jennifer MarloweExecutive Officer
- Ian SmithDirector
- Offering amount
- $9.2M
- Amount sold
- $9.2M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40MraisedOct 2020 · 1 investors · PharmaceuticalsRule 506(b)
- Ian SmithDirector
- Martin FreedDirector
- Lynne SullivanDirector
- Adam StoneDirector
- Matthew ArnoldDirector
- Rajeev ShahDirector
- Sukumar NagendranDirector
- Adam KoppelDirector
- Robert HuffinesDirector
- Joel SchneiderExecutive Officer
- Carl MorrisExecutive Officer
- Lynette HerschaExecutive Officer
- Ilan GanotExecutive Officer, Director
- Jennifer ZiolkowskiExecutive Officer
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$60MraisedJul 2019 · 15 investors · PharmaceuticalsRule 506(b)
- Carl MorrisExecutive Officer
- Martin FreedDirector
- Lynne SullivanDirector
- Ilan GanotExecutive Officer, Director
- Alvaro AmorrortuExecutive Officer
- Lynette HerschaExecutive Officer
- Andrey ZarurDirector
- Joel SchneiderExecutive Officer
- Jorge A. QuirozExecutive Officer
- Jennifer ZiolkowskiExecutive Officer
- Robert HuffinesDirector
- Adam KoppelDirector
- Sukumar NagendranDirector
- Rajeev ShahDirector
- Matthew ArnoldDirector
- Adam StoneDirector
- Offering amount
- $60M
- Amount sold
- $60M
- Sales commissions
- $1.8M
- Placement agents
- SVB Leerink LLC
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 3
Companies working in the same space as Solid Biosciences.
Frequently asked questions
- What does Solid Biosciences do?
- Solid Biosciences is a precision genetic medicine company developing a pipeline of gene therapy candidates for rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich's ataxia, CPVT, and TNNT2-mediated dilated cardiomyopathy. It also develops genetic regulator libraries and delivery platform technologies intended to improve gene therapy delivery.
- Who founded Solid Biosciences?
- Solid Biosciences was founded by Ilan Ganot.
- Who are Solid Biosciences's investors?
- Solid Biosciences's investors include Bain Capital Life Sciences, Foresite Capital, RA Capital, Bain Capital.
- How much funding has Solid Biosciences raised?
- Solid Biosciences has disclosed $109.2M raised across 3 of its 5 known rounds.
- Where is Solid Biosciences headquartered?
- Solid Biosciences is headquartered in Charlestown, US.